CVRX 8-K 2026-11-05

CVRx, Inc. (CVRX) 8-K dated 2026-11-05 — accession 0001104659-26-123332.

CVRx, Inc. (CVRX) is a medical devices company listed on US.

CVRX: CVRx Reports Third Quarter

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CVRX revenue for 2025-12-31 was $56.7M. Net income was -$53.3M. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. CVRX currently screens at market cap $142.8M.

Not investment advice. The CVRX SEC hub lists recent forms. The stock page is the research view.